Insulin-like growth factor 2 enhances insulinogenic differentiation of human eyelid adipose stem cells via the insulin receptor

Cell Proliferation

Volumn 44, Issue 3, 2011, Pages 254-263

  Kang, H M ^a   Park, S ^a   Kim, H ^a  

^a Seoul Women University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DITHIZONE; INSULIN; INSULIN RECEPTOR; PROTEIN C; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1;

ADIPOSE TISSUE CELL; ADULT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; EYELID; GENE EXPRESSION; GLUCOSE INTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; STAINING; STEM CELL;

ADIPOSE TISSUE; C-PEPTIDE; CELL DIFFERENTIATION; EYELIDS; GENE EXPRESSION PROFILING; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INSULIN-SECRETING CELLS; RECEPTOR, INSULIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 79955409832     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00755.x     Document Type: Article

References (42)

1. Navarro-Tableros V, Sánchez-Soto MC, García S, Hiriart M (2004) Autocrine regulation of single pancreatic beta-cell survival. Diabetes 53, 2018-2023.
2. Johnson JD, Bernal-Mizrachi E, Alejandro EU, Han Z, Kalynyak TB, Li H et al. (2006) Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc. Natl. Acad. Sci. USA 103, 19575-19580.
3. Cahuana GM, Tejedo JR, Hmadcha A, Ramírez R, Cuestal AL, Soria B et al. (2008) Nitric oxide mediates the survival action of IGF-1 and insulin in pancreatic beta cells. Cell. Signal. 20, 301-310.
4. Beith JL, Alejandro EU, Johnson JD (2008) Insulin stimulates primary β-cell proliferation via Raf-1 kinase. Endocrinology 149, 2251-2260.
5. Guillen C, Bartolomé A, Nevado C, Benito M (2008) Biphasic effect of insulin on beta cell apoptosis depending on glucose deprivation. FEBS Lett. 582, 3855-3860.
6. Hugl SR, White MF, Rhodes CJ (1998) Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J. Biol. Chem. 273, 17771-17779.
7. Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ (2002) Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 51, 966-976.
8. Hill DJ, Petrik J, Arany E, McDonald TJ, Delovitch TL (1999) Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice. J. Endocrinol. 161, 153-165.
9. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J et al. (2001) Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50, 1110-1118.
10. Lu Y, Herrera PL, Guo Y, Sun D, Tang Z, LeRoith D et al. (2004) Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes 53, 3131-3141.
11. Petrik J, Arany E, McDonald TJ, Hill DJ (1998) Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 139, 2994-3004.
12. Petrik J, Pell JM, Arany E, McDonald TJ, Dean WL, Reik W et al. (1999) Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140, 2353-2363.
13. Serradas P, Goya L, Lacorne M, Gangnerau MN, Ramos S, Alvarez C et al. (2002) Fetal insulin-like growth factor-2 production is impaired in the GK rat model of type 2 diabetes. Diabetes 51, 392-397.
14. Calderari S, Gananerau MN, Thibault M, Meile MJ, Kassis N, Alvarez C et al. (2007) Defective IGF2 and IGF1R protein production in embryonic pancreas precedes beta cell mass anomaly in the Goto-Kakizaki rat moder of type 2 diabetes. Diabetologia 50, 1463-1471.
15. Chang CM, Kao CL, Chang YL, Yang MJ, Chen YC, Sung BL et al. (2007) Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochem. Biophys. Res. Commun. 357, 414-420.
16. Jiang J, Au M, Lu K, Eshpeter A, Korbutt G, Fisk G et al. (2007) Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25, 1940-1953.
17. Jiang W, Shi Y, Zhao D, Chen S, Yong J, Zhang J et al. (2007) In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 17, 333-344.
18. Chao KC, Chao KF, Fu YS, Liu SH (2008) Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 3, e1451.
19. Zhao AZ, Zhao H, Teague J, Fujimoto W, Beavo JA (1997) Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc. Natl. Acad. Sci. USA 94, 3223-3228.
20. Kang HM, Kim J, Park S, Kim J, Kim H, Kim KS et al. (2009) Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells 27, 1999-2008.
21. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG et al. (2006) Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392-1401.
22. Phillips BW, Hentze H, Rust WL, Chen QP, Chipperfield H, Tan EK et al. (2007) Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev. 16, 561-578.
23. Lin HY, Tsai CC, Chen LL, Chiou SH, Wang YJ, Hung SC (2010) Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK. J. Biomed. Sci. 17, 56.
24. Hori Y, Gu X, Xie X, Kim SK (2005) Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med. 2, e103.
25. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y (2008) Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J. Biol. Chem. 283, 31601-31607.
26. Li G, Barrett EJ, Wang H, Chai W, Liu Z (2005) Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology 146, 4690-4696.
27. De Meyts P, Whittaker J (2002) Structural biology of insulin and IGF1 receptors: implications for drug design. Nat. Rev. Drug Discov. 1, 769-783.
28. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA (1990) Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J. 9, 2409-2413.
29. Muller D, Huang GC, Amiel S, Jones PM, Persaud SJ (2006) Identification of insulin signaling elements in human beta-cells: autocrine regulation of insulin gene expression. Diabetes 55, 2835-2842.
30. Miettinen PJ, Otonkoski T, Voutilainen R (1993) Insulin-like growth factor-II and transforming growth factor-alpha in developing human fetal pancreatic islets. J. Endocrinol. 138, 127-136.
31. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M (1995) Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res. 55, 2007-2011.
32. Ishiwata T, Bergmann U, Kornmann M, Lopez M, Beger HG, Korc M (1997) Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. Pancreas 15, 367-373.
33. Hawkes C, Kar S (2004) The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system. Brain Res. Rev. 44, 117-140.
34. Scott CD, Firth SM (2004) The role of the M6P/IGF-II receptor in cancer: tumor suppression or garbage disposal? Horm. Metab. Res. 36, 261-271.
35. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A et al. (1999) Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 19, 3278-3288.
36. Belfiore A (2007) The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr. Pharm. Des. 13, 671-686.
37. Wilson EM, Hsieh MM, Rotwein P (2003) Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J. Biol. Chem. 278, 41109-41113.
38. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN (2001) Selective signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol. Cell 7, 559-570.
39. Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, Belfiore A (2003) Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. J. Biol. Chem. 278, 42178-42189.
40. Sciacca L, Prisco M, Wu A, Belfiore A, Vigneri R, Baserga R (2003) Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. Endocrinology 144, 2650-2658.
41. Nevado C, Valverde AM, Benito M (2006) Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Endocrinology 147, 3709-3718.
42. Johnson D, Shepherd RM, Gill D, Gorman T, Smith DM, Dunne MJ (2007) Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. Diabetes 56, 1694-1702.